Eli Lilly and Company (LLY)
After hours:
| Previous Close | 901.25 |
| Open | 902.15 |
| Bid | 918.00 x 1000 |
| Ask | 922.25 x 1200 |
| Day's Range | 897.20 - 921.54 |
| 52 Week Range | 516.57 - 972.53 |
| Volume | |
| Avg. Volume | 3,210,222 |
| Market Cap | 829.193B |
| Beta (5Y Monthly) | 0.42 |
| PE Ratio (TTM) | 113.69 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 5.20 (0.56%) |
| Ex-Dividend Date | Aug 15, 2024 |
| 1y Target Est | N/A |
- Investor's Business Daily
Dow Jones Futures: Nvidia Leads Big Upside Market Reversal, 6 Stocks In Buy Areas (Live)
Nvidia and the Nasdaq led a big upside market reversal Wednesday. AppLovin led stocks in buy areas. Here's what to do now.
- Investor's Business Daily
Novo Jumps After Weight-Loss Pill Tops Wegovy; Lilly, Viking Shares Rise
Novo Nordisk stock rose moderately Wednesday after the pharma giant said its new weight-loss drug, amycretin, outperformed Wegovy.
- Bloomberg
Roche Shares Drop on Concern About Obesity Pill Side Effects
(Bloomberg) -- Roche Holding AG’s shares slid after its closely-watched experimental obesity pill was tied to side effects, including nausea and vomiting, in a small study.Most Read from BloombergHow Americans Voted Their Way Into a Housing CrisisAfter a Record Hot Summer, Pressure Grows for A/C MandatesFor Tenants, AI-Powered Screening Can Be a New Barrier to HousingChicago Halts Hiring as Deficit Tops $1 Billion Through 2025UC Berkeley Gives Transfer Students a Purpose-Built Home on CampusThe
